POMALYST® (pomalidomide) homepage

This site is intended for US audiences only.

POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.

The REMS Companion App

Easily access the POMALYST REMS® program.

Download now
An example of a cell with relapsed/refractory multiple myeloma
An example of a cell with relapsed/refractory multiple myeloma
ABOUT RELAPSED MULTIPLE MYELOMA

Relapse is an expected part of the multiple myeloma journey.

LEARN MORE
Hypothetical POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma and the My Momentum logo
Hypothetical POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma and the My Momentum logo

My Momentum

Join the support program for those who are taking POMALYST or those who want more information.

SIGN UP
Hypothetical caregiver and a POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma smiling
Hypothetical caregiver and a POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma smiling

Caregiver support

Caregivers play an important role in the multiple myeloma journey.

LEARN MORE

POMALYST is a once-daily capsule
that can be taken at home or
wherever is convenient for you.*

*POMALYST is taken in combination with dexamethasone on days 1-21 of a 28-day cycle.

Learn more

POMALYST is a once-daily capsule
that can be taken at home or
wherever is convenient for you.*

*POMALYST is taken in combination with dexamethasone on days 1-21 of a 28-day cycle.

Learn more

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.